Let's go! Call to action, part 1, FDA

Charles Eisenstein says that it’s time to push. I agree. But sometimes it’s hard to know where to direct one’s energies. I suggest that we put our shoulder to the wheel to push the FDA and CDC to reject COVID-19 vaccines for children.

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on Oct. 26 to discuss emergency use authorization of the Pfizer mRNA vaccine for children ages 5 to 11. Then the decision goes to the FDA Commissioner for her sign off.

Following the FDA decisions, Pfizer’s application will reviewed by the CDC’s Advisory Committee on Immunization Practices (ACIP) at their meeting on Nov. 2-3. And then the ACIP decision is reviewed by the CDC Director (the ever-anxious Rochelle Walensky).

The Biden Administration has already purchased 65 million doses of this vaccine for use in children. If we do nothing, these shots will start being injected into children within days of the ACIP decision.

This is clearly insane. The U.S. has engaged in a Herod-like systematic destruction of children since 1986 but this takes it to the next level. It’s hard to even know where to begin in describing the problems with Pfizer’s application because the entire scheme is based on junk science. But in the interests of moving the conversation forward, here are 3 reasons why the FDA (VRBPAC) and CDC (ACIP) must reject Pfizer’s EUA application to poison children ages 5 to 11:

---

3 reasons to reject Pfizer’s EUA application for mRNA shots for children ages 5 to 11:

1. Children are at extremely low risk of dying of COVID. How low? In a meta-analysis combining data from 11 countries, Stanford researchers Cathrine Axfors and John Ioannidis found a median infection fatality rate (IFR) of 0.0027% in children ages 0-19. Said differently, children infected with COVID have a 99.9973% survival rate. The IFR in children is so low that Pfizer’s clinical trials involving 2,300 kids did not detect any health benefit at all from their shots.

2. The vaccine does not work very well. A recent study from the Harvard Center for Population and Development Studies states it plainly: “Increases in COVID-19 are unrelated to level of vaccination across 68 countries and 2,947 counties in the United States.” Researchers found that, “countries with higher percentage of population fully vaccinated have higher COVID-19 cases per 1 million people. Notably, Israel with over 60% of their population fully vaccinated had the highest COVID-19 cases per 1 million people in the last 7 days.” 

3. The Pfizer mRNA vaccine causes catastrophic side effects, particularly heart inflammation (myocarditis and pericarditis) in youth. The CDC’s own analysis of “Myopericarditis following COVID-19 vaccination: Updates from the Vaccine Adverse Event Reporting System (VAERS)” showed astonishing increases particularly in children ages 12-15, 16-17, and 18-24.

The Pfizer vaccine fails any reasonable risk benefit analysis in connection with children.

---

So what can be done? To paraphrase the great environmentalist Utah Phillips, “The people who are harming us have names and addresses” and it is our democratic right to reach out and urge them to do the right thing. Below is a list of the 21 people who will make this decision at the FDA/VRBPAC (I will send out a second call to action regarding the CDC/ACIP). The first 2 people are key officials at the FDA. The remaining 19 have a vote on Tuesday at the VRBPAC meeting.

So here’s the plan: I need you to call, email, and fax these people to urge them to reject Pfizer’s EUA application for kids ages 5 to 11.

What to say on the phone:
Hi, my name is ____________. I’m calling to urge you to vote No on Pfizer’s EUA application for children ages 5 to 11. Pfizer has not demonstrated any health benefits for children and the potential harms are enormous. Thank you honoring your Hippocratic Oath and the Nuremberg Code by voting No.

What to put in an email? Choose 1:
Copy and paste the 3 reasons from above into your email; or
Come up with your own script (doesn’t have to be perfect, just jot down a few sentence and send it); or
Send Aaron Siri’s latest Substack article ; or
Send Alex Berenson’s latest Substack article.

If you still have a fax machine (or if you know how to send a fax through the internet) faxes are still extremely powerful (it’s a way to get a paper letter there immediately). Copy and paste the 3 reasons above into a Word document (or write your own message), address it to the person you are sending it to, print it, and send.

Here are the 21 people we need to reach before Tuesday, October 26:

Janet Woodcock
Acting FDA Commissioner
FDA, mail stop: HFD-001
10903 New Hampshire Ave., WO51-6133
Silver Spring MD 20993-0002
phone: (301) 796-5400
fax: (301) 847-8752
Janet.Woodcock@fda.hhs.gov

Peter Marks
Director, Center for Biologics Evaluation and Research
FDA, Mail stop: HFM-2
10903 New Hampshire Ave., WO71-7232
Silver Spring MD 20993-0002
phone: (240) 402-8116
fax: (301) 595-1310
Peter.Marks@fda.hhs.gov

Acting Chair, VRBPAC
Arnold Monto, M.D.
Professor of Public Health & Epidemiology
Department of Epidemiology
University of Michigan School of Public Health
Ann Arbor, MI 48109 
phone: (734) 764-5453
fax: (734) 764-3192
asmonto@umich.edu

Paula Annunziato, M.D.
Vice President and Therapeutic Area Head
Vaccines Clinical Research
Merck
North Wales, PA 19454
paula.annunziato@merck.com

Captain Amanda Cohn
Chief Medical Officer
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 MS C-09
phone: (404) 639-6039
acohn@cdc.gov

Hayley Gans, M.D.
Professor of Pediatrics
Department of Pediatrics
Stanford University Medical Center
Stanford, CA 94305
phone: (650) 723-5682
fax: (650) 725-8040
hgans@stanford.edu

Michael Kurilla, M.D., Ph.D.
Director, Division of Clinical Innovation
National Center for Advancing Translation Sciences
National Institutes of Health
Bethesda, MD 20852
phone: (301) 435-0178
Michael.kurilla@nih.gov

H. Cody Meissner, M.D.
Professor of Pediatrics
Tufts University School of Medicine
Director, Pediatric Infectious Disease
Tufts Medical Center
Boston, MA 02111
phone: (617) 636-5227
fax: (617) 636-4300
cmeissner@tuftsmedicalcenter.org

Paul Offit, M.D.
Professor of Pediatrics
Division of Infectious Diseases
Abramson Research Building
The Children’s Hospital of Philadelphia
Philadelphia, PA 19104
phone: (215) 590-2020
offit@chop.edu

Steven Pergam, M.D.
Medical Director
Infection Prevention
Seattle Cancer Care Alliance
Seattle, WA 98109
phone: (206) 667-7126
spergam@fredhutch.org

Temporary Voting Members (but their votes count all the same)

A. Oveta Fuller, Ph.D. 
Associate Professor of Microbiology and Immunology,
University of Michigan Medical School
Ann Arbor, MI 48109
phone: (734) 647-3830
fullerao@umich.edu

James Hildreth, Sr., Ph.D., M.D. 
Professor
Department of Internal Medicine
School of Medicine
President and Chief Executive Officer
Meharry Medical College
Nashville, TN 37205 
officeofthepresident@mmc.edu
https://twitter.com/JamesEKHildreth

Jeannette Lee, Ph.D. 
Professor Department of Biostatistics
University of Arkansas for Medical Sciences
Little Rock, AR 72701
phone: (501) 526-6712
JYLee@uams.edu 

Ofer Levy, M.D., Ph.D.
Staff Physician & Principal Investigator
Director, Precision Vaccines Program
Division of Infectious Diseases
Boston Children’s Hospital
Professor,
Harvard Medical School Associate Member
phone: (617) 919-2900
fax: (617) 730-0254
ofer.levy@childrens.harvard.edu

Patrick Moore, M.D., M.P.H. 
Distinguished and American Cancer Society Professor
Pittsburgh Foundation Chair in Innovative Cancer Research
University of Pittsburgh Cancer Institute
Pittsburgh, PA 15213 
phone: (412) 623-7721
psm9@pitt.edu

Michael Nelson, M.D., Ph.D. 
Professor of Medicine 
Asthma, Allergy and Immunology Division 
UVA Division of Asthma, Allergy & Immunology
PO Box 801355
Charlottesville, VA 22908
phone: (434) 297-8399
fax: (434) 924-5779
mrn8d@virginia.edu

Stanley Perlman, M.D., Ph.D.
Professor of Pediatrics
University of Iowa
3-712 Bowen Science Building (BSB)
51 Newton Rd
Iowa City, IA 52242
phone: (319) 335-8549
stanley-perlman@uiowa.edu

Jay Portnoy, M.D.
Director,
Division of Allergy, Asthma & Immunology
Children’s Mercy Hospitals & Clinics
2401 Gillham Road Kansas City, MO 64108
phone: (816) 960-8885
fax: (816) 960-8888
Jportnoy@cmh.edu

Eric Rubin, M.D., Ph.D. 
Editor-in-Chief
New England Journal of Medicine
Adjunct Professor
Harvard TH Chan School of Public Health
665 Huntington Ave
Building 1, Room 811
Boston, MA  02115
phone: (617) 432-3335
erubin@hsph.harvard.edu
erubin@nejm.org

Mark Sawyer, M.D.
Professor of Clinical Pediatrics 
8110 Birmingham Way
Bldg. 28, 1st Floor
San Diego, CA 92123
phone: (858) 966-7785
fax: (858) 966-8658
mhsawyer@ucsd.edu

Melinda Wharton, M.D., MPH
Associate Director for Vaccine Policy
National Center for Immunization and Respiratory Diseases,
Centers for Disease Control and Prevention,
1600 Clifton Road, Mailstop E05,
Atlanta, GA 30333
phone: (404) 639.8755
fax: (404) 639.8626
mew2@cdc.gov

Let’s do this! 🙌

(Let me know how you are going in the comments. Post any corrections there too and I will update this post.)